Eli Lilly, which has been directing patients to ... announcing a partnership Wednesday with major telehealth platform Ro. Under the new agreement, Ro patients who are prescribed Zepbound will ...

Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound available on telehealth platform Ro. Starting today, consumers can get an ...

Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss drug Zepbound through a new partnership with Eli Lilly. Ro directly ...

Ro partners with Eli Lilly to offer Zepbound, an FDA-approved obesity treatment, at affordable cash-pay prices through an ...

Lilly is investing billions of dollars to scale manufacturing efforts as demand for its weight loss treatments soar. The ...

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss drug directly to patients. The partnership will expand access to the ...

Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly ... arrangement, Ro will prescribe single-dose vials of Zepbound through its online platform that Lilly will fill ...

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients with obesity. The vials will be available as a treatment ...

Direct-to-consumer healthcare startup Ro announced Wednesday that its platform will now offer cheaper single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lillywhich ...